Supplemental Financial Information (Consolidating Statement of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Mar. 31, 2016	Jun. 30, 2016	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]
Cash flows from operating activities (1)					$ 602,271	$ 979,626	$ 758,596
Additions to properties, plants and equipment					(372,195)	(483,034)	(366,135)
Distribution from HEP					0	0
Proceeds from Sale of Other Assets					849	19,264	16,633
Purchase of equity method investment - HEP					(42,627)	(55,032)
Purchases of marketable securities					(546,632)	(509,338)	(1,025,602)
Sales and maturities of marketable securities					266,603	839,513	1,276,447
Other, net					0	0	5,021
Net cash provided by (used for) investing activities					(801,597)	(381,748)	(292,322)
Proceeds from (Repayments of) Lines of Credit						141,000
Proceeds from issuance of senior notes - HFC					992,550	0	0
Net proceeds from issuance of term loan					350,000	0	0
Repayment of term loan	$ (39,500)	$ (39,500)			(350,000)	0	0
Net proceeds from common unit offerings - HEP			$ 23,000	$ 103,000	125,870	0	0
Principal tender on senior notes – HEP						(155,156)	(156,188)
Purchase of treasury stock					(133,430)	(742,823)	(158,847)
Contribution from General Partner					0	0	0
Dividends					(234,004)	(246,908)	(647,197)
Payments of Ordinary Dividends, Noncontrolling Interest						(83,268)	(78,202)
Repayment of financing obligation					(39,500)	0	0
Excess tax benefit from equity-based compensation					0	0	2,040
Other, net					(10,507)	(12,175)	(7,998)
Net cash provided by (used for) financing activities					843,372	(1,099,330)	(838,392)
Increase (decrease) for the period					644,046	(501,452)	(372,118)
Beginning of period		66,533	66,533	66,533	66,533	567,985	940,103
End of period					710,579	66,533	567,985
Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Cash flows from operating activities (1)					460,918	839,106	653,570
Additions to properties, plants and equipment					(372,195)	(483,034)	(366,135)
Distribution from HEP					(278,000)	(62,000)
Proceeds from Sale of Other Assets					422	17,985	16,633
Purchase of equity method investment - HEP					0	0
Purchases of marketable securities					(546,632)	(509,338)	(1,025,602)
Sales and maturities of marketable securities					266,603	839,513	1,276,447
Other, net							5,021
Net cash provided by (used for) investing activities					(651,802)	(134,874)	(93,636)
Proceeds from issuance of senior notes - HFC					(992,550)
Proceeds from Issuance of Long-term Debt					0
Net proceeds from issuance of term loan					350,000
Repayment of term loan					(350,000)
Principal tender on senior notes – HEP						(155,156)	0
Purchase of treasury stock					(133,430)	(742,823)	(158,847)
Contribution from General Partner					(53,839)	(128,476)	(120,111)
Dividends					(234,004)	(246,908)	(647,197)
Payments of Ordinary Dividends, Noncontrolling Interest					0	0	0
Excess tax benefit from equity-based compensation							2,040
Other, net					(2,991)	(6,504)	(4,415)
Net cash provided by (used for) financing activities					846,286	(1,217,867)	(928,530)
Increase (decrease) for the period					655,402	(513,635)	(368,596)
Beginning of period		51,520	51,520	51,520	51,520	565,155	933,751
End of period					706,922	51,520	565,155
HEP Subsidiary
Condensed Financial Statements, Captions [Line Items]
Cash flows from operating activities (1)					(242,761)	(230,940)	(185,519)
Additions to properties, plants and equipment					0	0	0
Distribution from HEP					(278,000)	62,000
Proceeds from Sale of Other Assets					427	1,279	0
Purchase of equity method investment - HEP					(42,627)	55,032
Purchases of marketable securities					0	0	0
Sales and maturities of marketable securities					0	0	0
Other, net							0
Net cash provided by (used for) investing activities					(146,023)	246,874	198,686
Proceeds from (Repayments of) Lines of Credit					(159,000)	141,000	208,000
Proceeds from issuance of senior notes - HFC					0
Proceeds from Issuance of Long-term Debt					394,000
Net proceeds from issuance of term loan					0
Repayment of term loan					0
Net proceeds from common unit offerings - HEP					125,870
Principal tender on senior notes – HEP						0	(156,188)
Purchase of treasury stock					0	0	0
Contribution from General Partner					53,839	128,476	120,111
Dividends					0	0	0
Payments of Ordinary Dividends, Noncontrolling Interest					(197,787)	(173,688)	(158,695)
Repayment of financing obligation					(39,500)
Excess tax benefit from equity-based compensation							0
Other, net					(7,516)	(5,671)	(3,583)
Net cash provided by (used for) financing activities					(108,094)	28,117	9,645
Increase (decrease) for the period					(11,356)	12,183	(3,522)
Beginning of period		15,013	15,013	15,013	15,013	2,830	6,352
End of period					3,657	15,013	2,830
HEP
Condensed Financial Statements, Captions [Line Items]
Additions to properties, plants and equipment					(107,595)	(193,121)	(198,686)
Distribution from HEP					(62,000)
Purchase of equity method investment - HEP					(42,627)	(55,032)	0
Proceeds from (Repayments of) Lines of Credit					(159,000)		208,000
Proceeds from issuance of senior notes - HFC					394,000	0	0
Proceeds from Issuance of Long-term Debt					394,000
Net proceeds from common unit offerings - HEP					125,870
Principal tender on senior notes – HEP					0	0	(156,188)
Payments of Ordinary Dividends, Noncontrolling Interest					(92,607)
Repayment of financing obligation					(39,500)
Beginning of period		15,013	15,013	15,013	15,013
End of period					3,657	15,013
HEP | Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Additions to properties, plants and equipment					0	0	0
Proceeds from (Repayments of) Lines of Credit					0	0	0
Net proceeds from common unit offerings - HEP					0
Repayment of financing obligation					0
HEP | HEP Subsidiary
Condensed Financial Statements, Captions [Line Items]
Additions to properties, plants and equipment					(103,823)	(193,121)	(198,686)
Consolidations and Eliminations
Condensed Financial Statements, Captions [Line Items]
Cash flows from operating activities (1)					(101,408)	(90,420)	(80,493)
Additions to properties, plants and equipment					0	0	0
Distribution from HEP					0	0
Proceeds from Sale of Other Assets					0	0	0
Purchase of equity method investment - HEP					0	0
Purchases of marketable securities					0	0	0
Sales and maturities of marketable securities					0	0	0
Other, net							0
Net cash provided by (used for) investing activities					(3,772)	0	0
Proceeds from (Repayments of) Lines of Credit					0	0	0
Proceeds from issuance of senior notes - HFC					0
Proceeds from Issuance of Long-term Debt					0
Net proceeds from issuance of term loan					0
Repayment of term loan					0
Net proceeds from common unit offerings - HEP					0
Principal tender on senior notes – HEP						0	0
Purchase of treasury stock					0	0	0
Contribution from General Partner					0	0	0
Dividends					0	0	0
Payments of Ordinary Dividends, Noncontrolling Interest					105,180	90,420	80,493
Repayment of financing obligation					0
Excess tax benefit from equity-based compensation							0
Other, net					0	0	0
Net cash provided by (used for) financing activities					105,180	90,420	80,493
Increase (decrease) for the period					0	0	0
Beginning of period		$ 0	$ 0	$ 0	0	0	0
End of period					0	$ 0	$ 0
Consolidations and Eliminations | HEP
Condensed Financial Statements, Captions [Line Items]
Additions to properties, plants and equipment					$ (3,772)